Log in

Relevant bibliographies by topics / Cancer ablation / Books

To see the other types of publications on this topic, follow the link: Cancer ablation.

Books on the topic 'Cancer ablation'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 27 books for your research on the topic 'Cancer ablation.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Percutaneous tumor ablation: Strategies and techniques. New York: Thieme, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Kinoshita, Takayuki, ed. Non-surgical Ablation Therapy for Early-stage Breast Cancer. Tokyo: Springer Japan, 2016. http://dx.doi.org/10.1007/978-4-431-54463-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hong, Kelvin. Percutaneous tumor ablation: Strategies and techniques. New York: Thieme, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Radiofrequency Ablation for Cancer. New York: Springer-Verlag, 2004. http://dx.doi.org/10.1007/b97314.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Tumor Ablation Tumor Microenvironment. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Faddegon, Stephen, Ephrem O. Olweny, and Jeffrey A. Cadeddu. Ablative technologies for renal cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0087.

Full text

Abstract:

Nearly two-thirds of newly detected renal masses are clinical stage 1, with T1a tumours accounting for 60% of the newly detected stage 1 tumours. Guideline panels convened by the American Urological Association and the European Association of Urology recommend nephron-sparing surgery as the gold standard treatment for small renal masses, with active surveillance and thermal ablation recommended as alternative strategies in select patients. However, there is a dearth of studies directly comparing outcomes for energy-based ablation to those for traditional surgical treatments for small renal masses, and future prospective randomized trials will be invaluable in this regard. Ongoing research in renal tumour ablation targets several areas, including but not limited to achieving larger ablation sizes, decreasing morbidity, and development of novel technologies for renal tumour ablation.

APA, Harvard, Vancouver, ISO, and other styles

7

M, Ellis Lee, Curley Steven A, and Tanabe Kenneth K, eds. Radiofrequency ablation for cancer: Current indications, techniques, and outcomes. New York: Springer, 2004.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Radiofrequency ablation for cancer: Current indication, techniques, and outcomes. New York, NY: Springer, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

9

(Adapter), T. Livraghi, P. Mueller (Adapter), S. Silverman (Adapter), Eric vanSonnenberg (Editor), William McMullen (Editor), and Luigi Solbiati (Editor), eds. Tumor Ablation: Principles and Practice. Springer, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

(Editor), Lee M. Ellis, Steven A. Curley (Editor), and Kenneth K. Tanabe (Editor), eds. Radiofrequency Ablation for Cancer: Current Indications, Techniques and Outcomes. Springer, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

Ellis, Lee M. Radiofrequency Ablation for Cancer: "Current Indications, Techniques, And Outcomes". Springer, 2010.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kinoshita, Takayuki. Non-surgical Ablation Therapy for Early-stage Breast Cancer. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Focal Liver Lesions: Detection, Characterization, Ablation (Medical Radiology). Springer, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Miao, Yi. Experimental Research on Radiofrequency Tissue Ablation As an Alternative in Cancer Therapy. Leuven Univ Pr, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Polascik, Thomas J. Imaging and Focal Therapy of Early Prostate Cancer. Springer, 2018.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

Polascik, Thomas J. Imaging and Focal Therapy of Early Prostate Cancer. Springer, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

Imaging And Focal Therapy Of Early Prostate Cancer. Humana Press, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

The Prostate Cancer Dilemma: Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy. Springer, 2016.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

19

Stone, Nelson N., and E. David Crawford. The Prostate Cancer Dilemma: Selecting Patients for Active Surveillance, Focal Ablation and Definitive Therapy. Springer, 2015.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

20

(Foreword), A. L. Baert, R. Lencioni (Editor), D. Cioni (Editor), and C. Bartolozzi (Editor), eds. Focal Liver Lesions: Detection, Characterization, Ablation (Medical Radiology / Diagnostic Imaging). Springer, 2005.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

21

Kahn, S. Lowell. Bland Lipiodol-Assisted Thermal Ablation of Renal Cell Carcinoma. Edited by S. Lowell Kahn, Bulent Arslan, and Abdulrahman Masrani. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199986071.003.0073.

Full text

Abstract:

Surgical resection of renal cell carcinoma (RCC) remains the standard of care given the excellent reported outcomes for early stage disease, with 5-year cancer-specific survival (CSS) rates of 97% for pT1a and 87% for pT1b tumors after nephrectomy. Outcomes after partial nephrectomy are equally encouraging, with 5- and 10-year CSS rates of 92% and 80%, respectively, across all stages and 96% and 90%, respectively, for tumors less than 4 cm. Transarterial embolization prior to thermal ablation for RCC is far less frequent, but it is described in the literature. To date, there are no randomized controlled studies that demonstrate a benefit of combined therapy over radiofrequency ablation (RFA) or cryoablation alone. However, lipiodol is profoundly radiopaque, and utilization prior to RFA or cryoablation may aid in the visualization of the tumor.

APA, Harvard, Vancouver, ISO, and other styles

22

Bansal, Anshuman, and Fereidoun Abtin. Taming Cryoablation for Lung Tumors. Edited by S. Lowell Kahn, Bulent Arslan, and Abdulrahman Masrani. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199986071.003.0072.

Full text

Abstract:

This chapter details the indications, uses, and techniques of using percutaneous cryoablation to treat lung tumors. The chapter reviews the role of ablative therapy for primary lung cancers as well as metastatic disease to the lung. It reviews the basic physical principles of cryoablation and the advantages of percutaneous cryoablation compared to other percutaneous heat-based ablative modalities. Patient selection criteria and post-ablation follow-up protocols are discussed. The chapter reviews procedural considerations, including choice of anesthesia, patient positioning, probe trajectory, and post-procedural recovery. It also details techniques that can be used to minimize and treat complications as well as tips for treating more challenging lesions.

APA, Harvard, Vancouver, ISO, and other styles

23

Ablative Procedures In Surgical Oncology. W.B. Saunders Company, 2011.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

24

Kastler, Adrian, and Bruno Kastler. Cervical Sympathetic Block and Neurolysis: Computed Tomography. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199908004.003.0029.

Full text

Abstract:

The stellate ganglion blockade technique is used to treat complex regional pain syndrome (CRPS). It is now well established that stellate blockades should be performed under imaging guidance. It has been suggested that alcohol may bring longer lasting relief in cases of severe intractable cancer-related pain arising from regional neoplasms invading the stellate ganglion, but frequent onset of Horner’s syndrome can outweigh the technique’s efficacy. Radiofrequency neurolysis (RFN) has become a common procedure in the management of chronic neuropathic pain. This chapter reviews indications of stellate ganglion procedures and describes the basic anatomical background, as knowledge of the anatomical surroundings of the stellate ganglion is a necessary prerequisite to a safe and successful procedure. Then it demonstrates how CT-guidance allows a step-by-step control of positioning the needle tip at target for either alcohol or radiofrequency thermal ablation, and discusses the results, advantages, and disadvantages of each approach.

APA, Harvard, Vancouver, ISO, and other styles

25

Ahmed, Hashim Uddin, Louise Dickinson, and Mark Emberton. Focal therapy for prostate cancer. Edited by James W. F. Catto. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199659579.003.0065.

Full text

Abstract:

Minimally-invasive therapies in localized prostate cancer offer the potential to reduce side effects and the healthcare burden/costs associated with radical modalities such as surgery or radiotherapy. As radical treatments carry significant perioperative morbidity (wound infection, haemorrhage, hospital stay), potentially life-long side effects (such as incontinence, erectile dysfunction, rectal toxicity), and fail to cure many men, ablative therapies that reduce treatment burden while retaining acceptable cancer control have increasingly become areas of evaluation. This chapter reviews the role of these approaches and the therapeutic dilemma that men with localized low volume prostate cancer currently face as in the context of novel therapies which aim to find a middle ground—tissue-preserving focal therapy—that follows the paradigm of almost all other solid organ cancers.

APA, Harvard, Vancouver, ISO, and other styles

26

Brown, Jim, and Neal Navani. Non-surgical management of early-stage lung cancer. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199657742.003.0004.

Full text

Abstract:

As low-dose computed tomography screening of ‘high-risk’ smokers is occurring with increasing frequency, the incidental discovery of solitary pulmonary nodules is becoming more frequent, and lung cancer multidisciplinary teams are now often faced with balancing risk and benefit when making decisions regarding the radical treatment of patients with a clinical diagnosis of early lung cancer but borderline fitness. Surgery offers the best prospect of cure but is associated with significant mortality and morbidity; the elderly and frail experience more toxicity and a greater impact on the quality of life. This chapter reviews the criteria for assessing surgical fitness and examines the evidence for minimally invasive and ablative techniques for the treatment of early peripheral lung cancer in the medically inoperable patient.

APA, Harvard, Vancouver, ISO, and other styles

27

Burke, A., D. Carroll, Frank Torti, and S. V. Torti. Bifunctional nanomaterials for the imaging and treatment of cancer. Edited by A. V. Narlikar and Y. Y. Fu. Oxford University Press, 2017. http://dx.doi.org/10.1093/oxfordhb/9780199533060.013.13.

Full text

Abstract:

This article examines the potential of bifunctional nanomaterials for the imaging and treatment of cancer. Several nanomaterials possess properties desirable for a cancer therapy and have been the subject of research as anticancer agents. Those that have received the most attention include encapsulated iron oxides, single- and multiwalled carbon nanotubes, gold nanorods and gold nanoshells. This article first considers thermal ablative therapy incancer, focusing on the mechanisms of thermotoxicity and thermoresistance before discussing a number of nanomaterials with applications for cancer treatment. In particular, it evaluates the use of nanomaterials in thermal therapy. It also looks at gold nanoshells and nanorods, taking into account their physical properties, and concludes with an assessment of iron-oxide nanoparticles and future directions for nanomaterials as multifunctional agents for cancer therapy.

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!